Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea

Sleep Medicine

Volumn 15, Issue 7, 2014, Pages 762-768

  Hall, Trygve Sørdahl ^a,b   Herrscher, Tobias Erik ^a,b   Jarolim, Petr ^c   Fagerland, Morten Wang ^d   Jensen, Torstein ^a   Agewall, Stefan ^b,d   Atar, Dan ^b,d   Hallén, Jonas ^e  

^a LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Medical Affairs Boehringer Ingelheim Norway KS   (Norway)

Author keywords

Body mass index; C reactive protein; Inflammation; Myeloid related protein 8 14; Obstructive sleep apnea; Sleep disordered breathing

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MULTICHANNEL RECORDER; OBESITY; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; MIDDLE AGED;

ADULT; C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84901986041     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.03.008     Document Type: Article

References (40)

1. Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900.
2. Shah N.A., Yaggi H.K., Concato J., Mohsenin V. Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 2010, 14:131-136.
3. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
4. Cook N.R., Buring J.E., Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006, 145:21-29.
5. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
6. Murao S. Two calcium-binding proteins, MRP8 and MRP14: a protein complex associated with neutrophil and monocyte activation. Acta Histochem Cytochem 1994, 27:107-116.
7. Frosch M., Strey A., Vogl T., Wulffraat N.M., Kuis W., Sunderkotter C., et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:628-637.
8. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
9. Boyd J.H., Kan B., Roberts H., Wang Y., Walley K.R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008, 102:1239-1246.
10. Tan K.C., Chow W.S., Lam J.C., Lam B., Bucala R., Betteridge J., et al. Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep 2006, 29:329-333.
11. Mokhlesi B., Gozal D. In the fight against advanced glycation end-products (AGEs), you should treat OSA, shouldn't you?. Sleep Med 2012, 13:5-6.
12. Lam J.C., Tan K.C., Lai A.Y., Lam D.C., Ip M.S. Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea. Sleep Med 2012, 13:15-20.
13. Croce K., Gao H., Wang Y., Mooroka T., Sakuma M., Shi C., et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120:427-436.
14. Morrow D.A., Wang Y., Croce K., Sakuma M., Sabatine M.S., Gao H., et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J 2008, 155:49-55.
15. Healy A.M., Pickard M.D., Pradhan A.D., Wang Y., Chen Z., Croce K., et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006, 113:2278-2284.
16. Schaub N., Reichlin T., Meune C., Twerenbold R., Haaf P., Hochholzer W., et al. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2012, 58:246-256.
17. Vora A.N., Bonaca M.P., Ruff C.T., Jarolim P., Murphy S., Croce K., et al. Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain. J Thromb Thrombolysis 2012, 34:229-234.
18. Altwegg L.A., Neidhart M., Hersberger M., Muller S., Eberli F.R., Corti R., et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007, 28:941-948.
19. Chen Y.S., Yan W., Geczy C.L., Brown M.A., Thomas R. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res Ther 2009, 11:R39.
20. Kim J., Bhattacharjee R., Snow A.B., Capdevila O.S., Kheirandish-Gozal L., Gozal D. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J 2010, 35:843-850.
21. Kim J., Lee S., Bhattacharjee R., Khalyfa A., Kheirandish-Gozal L., Gozal D. Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea. Chest 2010, 138:91-99.
22. Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930-1932.
23. Calabro P., Chang D.W., Willerson J.T., Yeh E.T. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005, 46:1112-1113.
24. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671-674.
25. Arnardottir E.S., Maislin G., Schwab R.J., Staley B., Benediktsdottir B., Olafsson I., et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012, 35:921-932.
26. Punjabi N.M., Beamer B.A. C-Reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007, 30:29-34.
27. Sharma S.K., Mishra H.K., Sharma H., Goel A., Sreenivas V., Gulati V., et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 2008, 9:149-156.
28. Svensson M., Venge P., Janson C., Lindberg E. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res 2012, 21:147-154.
29. Nadeem R., Molnar J., Madbouly E.M., Nida M., Aggarwal S., Sajid H., et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013, 9:1003-1012.
30. Xie X., Pan L., Ren D., Du C., Guo Y. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 2013, 14:1139-1150.
31. Iber C., Ancoli-Israel S., Chesson A., Quan S.F. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, for the American Academy of Sleep Medicine, American Academy of Sleep Medicine, Westchester, IL. 1st ed.
32. Dati F., Schumann G., Thomas L., Aguzzi F., Baudner S., Bienvenu J., et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996, 34:517-520.
33. Lydersen S., Fagerland M.W., Laake P. Recommended tests for association in 2×2 tables. Stat Med 2009, 28:1159-1175.
34. Kohler M., Stradling J.R. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010, 7:677-685.
35. Arcari A., Zito F., Di C.A., De C.A., Dirckx C., Arnout J., et al. C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project. J Thromb Haemost 2008, 6:436-443.
36. Fredrikson G.N., Hedblad B., Nilsson J.A., Alm R., Berglund G., Nilsson J. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004, 53:1436-1442.
37. Frohlich M., Imhof A., Berg G., Hutchinson W.L., Pepys M.B., Boeing H., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000, 23:1835-1839.
38. Herrscher T.E., Overland B., Sandvik L., Westheim A.S., Akre H. High cardiovascular risk profile in patients with sleep apnea. Laryngoscope 2014, 124:306-310.
39. Lawlor D.A., Smith G.D., Rumley A., Lowe G.D., Ebrahim S. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. Thromb Haemost 2005, 93:955-963.
40. Edgeworth J., Gorman M., Bennett R., Freemont P., Hogg N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991, 266:7706-7713.